Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Severe, prolonged thrombocytopenia in a patient sensitive to exenatide.

Vallatharasu Y, Hayashi-Tanner Y, Polewski PJ, Bottner WA, Rosenstein LJ, Uprety D, Bista A, Farnen JP, Aster R.

Am J Hematol. 2019 Mar;94(3):E78-E80. doi: 10.1002/ajh.25381. Epub 2018 Dec 28. No abstract available.

PMID:
30575104
2.

Rebuilding Mercy Hospital Joplin.

Farnen J.

Health Prog. 2016 May-Jun;97(3):44-5. No abstract available.

PMID:
27333684
3.

Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

Xu-Monette ZY, Tu M, Jabbar KJ, Cao X, Tzankov A, Visco C, Nagarajan L, Cai Q, Montes-Moreno S, An Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, Møller MB, Farnen JP, Winter JN, Piris MA, Miranda RN, Medeiros LJ, Young KH.

Oncotarget. 2015 Jun 10;6(16):14720. No abstract available.

4.

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.

Fenske TS, Shah NM, Kim KM, Saha S, Zhang C, Baim AE, Farnen JP, Onitilo AA, Blank JH, Ahuja H, Wassenaar T, Qamar R, Mansky P, Traynor AM, Mattison RJ, Kahl BS.

Cancer. 2015 Oct 1;121(19):3465-71. doi: 10.1002/cncr.29502. Epub 2015 Jun 16.

5.

Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.

Xu-Monette ZY, Tu M, Jabbar KJ, Cao X, Tzankov A, Visco C, Nagarajan L, Cai Q, Montes-Moreno S, An Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, Møller MB, Farnen JP, Winter JN, Piris MA, Miranda RN, Medeiros LJ, Young KH.

Oncotarget. 2015 Mar 20;6(8):5615-33. Erratum in: Oncotarget. 2015 Jun 10;6(16):14720. Nagarajan, Lalitha [Added].

6.

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.

Chen J, Xu-Monette ZY, Deng L, Shen Q, Manyam GC, Martinez-Lopez A, Zhang L, Montes-Moreno S, Visco C, Tzankov A, Yin L, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, Møller MB, Farnen JP, Winter JN, Piris MA, Pham L, Young KH.

Oncotarget. 2015 Mar 20;6(8):5597-614.

7.

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma.

Ok CY, Chen J, Xu-Monette ZY, Tzankov A, Manyam GC, Li L, Visco C, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Zhao X, Ponzoni M, Ferreri AJ, Bertoni F, Farnen JP, Møller MB, Piris MA, Winter JN, Medeiros LJ, Young KH.

Clin Cancer Res. 2014 Oct 1;20(19):5113-23. doi: 10.1158/1078-0432.CCR-14-0683. Epub 2014 Aug 14.

8.

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

Ok CY, Xu-Monette ZY, Tzankov A, O'Malley DP, Montes-Moreno S, Visco C, Møller MB, Dybkaer K, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Han van Krieken J, Ponzoni M, Farnen JP, Piris MA, Winter JN, Medeiros LJ, Young KH.

Cancer. 2014 Jun 15;120(12):1818-29. doi: 10.1002/cncr.28664. Epub 2014 Mar 19.

9.

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

Ok CY, Li L, Xu-Monette ZY, Visco C, Tzankov A, Manyam GC, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Chen J, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ai W, Ponzoni M, Ferreri AJ, Farnen JP, Møller MB, Bueso-Ramos CE, Miranda RN, Winter JN, Piris MA, Medeiros LJ, Young KH.

Clin Cancer Res. 2014 May 1;20(9):2338-49. doi: 10.1158/1078-0432.CCR-13-3157. Epub 2014 Feb 28. Erratum in: Clin Cancer Res. 2014 Sep 15;20(18):4974. Dybaer, Karen [corrected to Dybkaer, Karen].

10.

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Tzankov A, Xu-Monette ZY, Gerhard M, Visco C, Dirnhofer S, Gisin N, Dybkaer K, Orazi A, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Ponzoni M, Ferreri AJ, Ye Q, Winter JN, Farnen JP, Piris MA, Møller MB, You MJ, McDonnell T, Medeiros LJ, Young KH.

Mod Pathol. 2014 Jul;27(7):958-71. doi: 10.1038/modpathol.2013.214. Epub 2013 Dec 13.

11.

Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis.

Obinwanne KM, Fredrickson KA, Mathiason MA, Kallies KJ, Farnen JP, Kothari SN.

J Am Coll Surg. 2014 Feb;218(2):246-52. doi: 10.1016/j.jamcollsurg.2013.10.023. Epub 2013 Nov 1.

PMID:
24315892
12.

Ascorbic acid deficiency in bariatric surgical population.

Riess KP, Farnen JP, Lambert PJ, Mathiason MA, Kothari SN.

Surg Obes Relat Dis. 2009 Jan-Feb;5(1):81-6. doi: 10.1016/j.soard.2008.06.007. Epub 2008 Jul 9.

PMID:
18996765
13.

Circulating endothelial cells in patients with chronic lymphocytic leukemia.

Go RS, Jobe DA, Asp KE, Callister SM, Mathiason MA, Meyer LA, Bottner WA, Cole CE, Farnen JP, Frisby KA.

Ann Hematol. 2008 May;87(5):369-73. doi: 10.1007/s00277-007-0435-y. Epub 2008 Jan 12.

PMID:
18193423
14.

Recurrent hypoglycemia and hypothermia in a patient with Hodgkin's disease.

Kulkarni A, Zlabek J, Farnen J, Capla R.

Haematologica. 2006 Dec;91(12 Suppl):ECR50.

15.

Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.

Johnston KL, Farnen JP, Manske BR, Go RS.

Haematologica. 2005 Dec;90(12 Suppl):EIM03. No abstract available.

16.

Human cyclic thrombocytopenia and Anaplasma spp. infection.

Go RS, Lovrich SD, Callister SM, Meyer LA, Bottner WA, Farnen JP.

Eur J Haematol. 2005 Feb;74(2):182-3. No abstract available.

PMID:
15654914
17.

Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993).

Dutcher JP, Lee S, Gallagher RE, Makary AZ, Hines JD, Londer H, Farnen JP, Bennett JM, Paietta E, Rowe JM, Goloubeva O, Wiernik PH; Eastern Cooperative Oncology Group.

Leuk Lymphoma. 2005 Mar;46(3):377-85.

PMID:
15621827
18.

Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.

Farnen JP, Tyrkus M, Hanson CA, Cody RL, Emerson SG.

Leukemia. 1991 Jul;5(7):574-84.

PMID:
1649357
19.

Acute lymphoblastic leukemia with eosinophilia.

Fishel RS, Farnen JP, Hanson CA, Silver SM, Emerson SG.

Medicine (Baltimore). 1990 Jul;69(4):232-43.

PMID:
2374508

Supplemental Content

Loading ...
Support Center